VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
Management of hyperlipidaemia among statin-intolerant patients after acute coronary syndrome: where do we stand in 2020?
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. Curr Atheroscler Rep. 2016 10; 18(10):61.
View in:
PubMed
subject areas
Anticholesteremic Agents
ATP Citrate (pro-S)-Lyase
Cholesterol, LDL
Dicarboxylic Acids
Drug Therapy, Combination
Ezetimibe
Fatty Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
authors with profiles
CHRISTIE BALLANTYNE